Certara is dedicated to improving human health by offering a broad spectrum of software products and services from early drug discovery through clinical drug development, with special focus on supporting translational approaches to drug development. Formed from the blending of Tripos, Pharsight, and most recently, Simcyp, to bring together world-class scientific consulting services and software, Certara leverages nearly 50 years of combined expertise in modeling, analysis, and simulation methods, from molecular modeling, to prediction of drug-drug interaction, and clinical trial simulation, to accelerate decision making and enable the cross-disciplinary approaches necessary for translational science.
At Certara, we understand that much of what the industry is seeking today in translational science is aimed at the movement and management of information. It’s about making information more accessible, sharing data across projects and across project teams, and bringing safety assessment of lead compounds into earlier stages of the drug development process – all to better utilize corporate resources to improve the effectiveness of drug development. Learn More
Leveraging 50 years of combined expertise in modeling, analysis, and simulation methods, Certara supports translational science needs.
Certara’s experience in scientific informatics and predictive science provides our clients with a unique set of capabilities for translational science initiatives by empowering true end-to-end solutions from discovery, through preclinical and clinical trials. Learn More
Certara offers predictive science and informatics solutions that enable cross-disciplinary and translational approaches to drug development.
Certara offers informatics solutions that allow scientists to more quickly and effectively access and analyze key data, and predictive science that enables critical safety assessments to be made earlier in drug discovery and development. Learn More
Search Our Archives